The European Commission and the European Medicines Agency have issued orphan drug designation to PROLOR Biotech's hGH-CTP. The longer-acting version of human growth hormone, hGH-CTP, is being developed to treat growth hormone deficiency. ...
Tags: PROLOR Biotech, hGH-CTP, European Orphan Drug Designation
Biotech has rceived a notice of allowance from the USPTO for a patent application covering the company's long-acting CTP-enhanced human growth hormone (hGH-CTP). Once the patent is issued, PROLOR would gain additional intellectual ...
Tags: PROLOR, CTP platform, human growth hormone